Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Jun 17;141(3):1060–1073.e3. doi: 10.1016/j.jaci.2017.05.030

Figure 1. Relative disease severity score in AD EDA-ID patients.

Figure 1

A. Cumulative disease severity score expressed as a percentage of the maximal score based on the evaluable disease criteria listed in Table 2. B. Individual disease category scores for patients with IκBα point mutations and patients with IκBα truncations. *, p<0.05; **, p<0.01; ***, p<0.001; ns, not significant; na, not applicable.